FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042999080> ?p ?o ?g. }

• W2042999080 abstract "Emerging evidence suggests modulating the microbiota in the large bowel of patients with chronic kidney disease (CKD) through pre- and/probiotic supplementation may inhibit the development of key nephrovascular toxins. To date, quality intervention trials investigating this novel treatment in CKD are lacking. The aim of SYNERGY is to assess the effectiveness of synbiotics (co-administration of pre- and probiotics) as a potential treatment targeting the synthesis of uremic toxins, specifically, indoxyl sulphate (IS) and p-cresyl sulphate (PCS).Thirty-seven patients with moderate to severe CKD (Stage IV and V, pre-dialysis) will be recruited to a double-blind, placebo-controlled, randomised cross-over trial. Patients will be provided with synbiotic therapy or placebo for 6 weeks, with a 4 week washout before cross-over. The primary outcome is serum IS, total and free (unbound) concentrations, measured using ultra-performance liquid chromatography. Secondary outcomes include serum PCS, total and free (unbound) concentrations; cardiovascular risk, measured by serum lipopolysaccharides, serum trimethylamine-N-oxide (TMAO) and inflammation and oxidative stress markers; kidney damage, measured by 24 hour proteinuria and albuminuria, estimated glomerular filtration rate and renal tubule damage (urinary kidney injury molecule-1); patients' self assessed quality of life; and gastrointestinal symptoms. In addition, the effects on the community structure of the stool microbiota will be explored in a subset of patients to validate the mechanistic rationale underpinning the synbiotic therapy.IS and PCS are two novel uremic toxins implicated in both cardiovascular disease (CVD) and progression of CKD. Preliminary studies indicate that synbiotic therapy maybe a promising strategy when considering a targeted, tolerable and cost-efficient therapy for lowering serum IS and PCS concentrations. This trial will provide high quality 'proof-of-concept' data to elucidate both the efficacy of synbiotic therapy for lowering the toxins and whether reductions in serum IS and PCS translate into clinical benefits. Considering the potential of pre- and probiotics to not only shift toxin levels, but to also impede CVD and CKD progression, SYNERGY will provide vital insight into the effectiveness of this innocuous nutritional therapy.Universal Trial Number: U1111-1142-4363. Australian New Zealand Clinical Trials Registry Number: ACTRN12613000493741, date registered: 2nd May 2013." @default.
• W2042999080 created "2016-06-24" @default.
• W2042999080 creator A5001559641 @default.
• W2042999080 creator A5004335767 @default.
• W2042999080 creator A5007936747 @default.
• W2042999080 creator A5011660710 @default.
• W2042999080 creator A5012260179 @default.
• W2042999080 creator A5014732746 @default.
• W2042999080 creator A5016939273 @default.
• W2042999080 creator A5043394711 @default.
• W2042999080 creator A5044112673 @default.
• W2042999080 creator A5056049381 @default.
• W2042999080 date "2014-07-04" @default.
• W2042999080 modified "2023-10-06" @default.
• W2042999080 title "SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial" @default.
• W2042999080 cites W122717592 @default.
• W2042999080 cites W1482976729 @default.
• W2042999080 cites W1873092804 @default.
• W2042999080 cites W190518456 @default.
• W2042999080 cites W1922511005 @default.
• W2042999080 cites W1967464752 @default.
• W2042999080 cites W1968286086 @default.
• W2042999080 cites W1969156144 @default.
• W2042999080 cites W1971266941 @default.
• W2042999080 cites W1971719229 @default.
• W2042999080 cites W1976926198 @default.
• W2042999080 cites W1986892606 @default.
• W2042999080 cites W1987614901 @default.
• W2042999080 cites W1994800928 @default.
• W2042999080 cites W1997832120 @default.
• W2042999080 cites W1998272935 @default.
• W2042999080 cites W1998829486 @default.
• W2042999080 cites W2002138274 @default.
• W2042999080 cites W2005569822 @default.
• W2042999080 cites W2010081625 @default.
• W2042999080 cites W2010283901 @default.
• W2042999080 cites W2018213438 @default.
• W2042999080 cites W2020141714 @default.
• W2042999080 cites W2039011877 @default.
• W2042999080 cites W2040137092 @default.
• W2042999080 cites W2062504921 @default.
• W2042999080 cites W2068166362 @default.
• W2042999080 cites W2068574968 @default.
• W2042999080 cites W2068894782 @default.
• W2042999080 cites W2069593112 @default.
• W2042999080 cites W2072970694 @default.
• W2042999080 cites W2078599166 @default.
• W2042999080 cites W2080797021 @default.
• W2042999080 cites W2083667648 @default.
• W2042999080 cites W2086124255 @default.
• W2042999080 cites W2095159087 @default.
• W2042999080 cites W2101431807 @default.
• W2042999080 cites W2109546786 @default.
• W2042999080 cites W2113750014 @default.
• W2042999080 cites W2114683153 @default.
• W2042999080 cites W2117065897 @default.
• W2042999080 cites W2122483069 @default.
• W2042999080 cites W2125891249 @default.
• W2042999080 cites W2127257837 @default.
• W2042999080 cites W2129559166 @default.
• W2042999080 cites W2133632336 @default.
• W2042999080 cites W2137496003 @default.
• W2042999080 cites W2143986083 @default.
• W2042999080 cites W2146023336 @default.
• W2042999080 cites W2150504315 @default.
• W2042999080 cites W2150895033 @default.
• W2042999080 cites W2155850242 @default.
• W2042999080 cites W2156565952 @default.
• W2042999080 cites W2156796015 @default.
• W2042999080 cites W2159488711 @default.
• W2042999080 cites W2159944550 @default.
• W2042999080 cites W2162208330 @default.
• W2042999080 cites W2162323969 @default.
• W2042999080 cites W2164058748 @default.
• W2042999080 cites W2164342861 @default.
• W2042999080 cites W2164819474 @default.
• W2042999080 cites W2166171121 @default.
• W2042999080 cites W2170947953 @default.
• W2042999080 cites W2171060095 @default.
• W2042999080 cites W2171540831 @default.
• W2042999080 cites W2269974365 @default.
• W2042999080 cites W2331176038 @default.
• W2042999080 cites W2339409444 @default.
• W2042999080 cites W2411365636 @default.
• W2042999080 doi "https://doi.org/10.1186/1471-2369-15-106" @default.
• W2042999080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4094543" @default.
• W2042999080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24996842" @default.
• W2042999080 hasPublicationYear "2014" @default.
• W2042999080 type Work @default.
• W2042999080 sameAs 2042999080 @default.
• W2042999080 citedByCount "42" @default.
• W2042999080 countsByYear W20429990802015 @default.
• W2042999080 countsByYear W20429990802016 @default.
• W2042999080 countsByYear W20429990802017 @default.
• W2042999080 countsByYear W20429990802018 @default.
• W2042999080 countsByYear W20429990802019 @default.
• W2042999080 countsByYear W20429990802020 @default.
• W2042999080 countsByYear W20429990802021 @default.
• W2042999080 countsByYear W20429990802022 @default.
• W2042999080 countsByYear W20429990802023 @default.

• next